Make Money With 3D Printing
According to Ken Jin, co-founder, and chief technology officer of Meditool, “Meditool is one of the pioneers in developing 3D printed PEEK medical implants. Evonik has been our trusted partner in materials supply. The venture investment will be an extra boost to our endeavor to bring innovative solutions to patients and surgeons in China and the rest of the world.”
Evonik’s venture capital arm has already invested in two funds in China and with Meditool, it now has its first direct investment. Co-investors in Meditool include ZN Ventures, Morningside Ventures, and Puhua Capital.
Materialise incorporates nearly 30 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry.
According to Materialise,” Let’s discuss ways how we can empower people to design, collaborate, build, and fabricate in more sustainable ways, while reducing waste, saving money, and staying competitive. At the end of the second quarter of 2019, the total commitment of lease assets and liabilities amounted to 5,050 kEUR. Our Adjusted EBITDA for the second quarter of 2019 was affected positively by the new standard as a result of the rental payments decrease of 644 kEUR; however, our operating profit was impacted by only 52 kEUR as depreciation expenses increased by 593 kEUR.
Materialise, Will acquire a mix of existing and new shares bringing its total shareholding to 75%, with the founding shareholders retaining the remaining 25%. All shares will be fully paid for in cash at the closing, which is expected to take place during the week of August 5, 2019.”
According to Materialise reports the Second quarter and now, 2019 Results, Executive Chairman Peter Leys commented, “In spite of a macro-economic environment that continues to be challenging, Materialise reported another quarter of top-line growth. This was mainly driven by Materialise Medical, which continued to perform strongly with solid revenue growth and EBITDA performance, and also by Materialise Manufacturing, which realized a double-digit EBITDA margin and grew its revenues for the third consecutive quarter.
This quarter, the contribution by Materialise Software to our revenue growth and Adjusted EBITDA margin was below our expectations as a number of sales were pushed out to the second half of the year. Our outlook for 2019 remains within our previous guidance range, with our results now including expected contributions from our August acquisition of a 75% stake in Engimplan.
This investment, which will enable us to introduce the benefits of Materialise’s patient-specific 3D printing implants and expertise to the fast-growing Brazil market, is part of our strategy to accelerate our growing presence in the additive manufacturing ecosystem through carefully selected acquisitions and partnerships.”
Physna: Compare thousands of 3D models in seconds,
According to Physna’s CEO Paul Powers and Glenn Warner, “Through revolutionary artificial intelligence, Physna uses advanced algorithms to dissect and analyze 3D objects in the blink of an eye.
Many companies have collectively spent billions of dollars on this problem. The reason that Physna is the first to actually fix it is that we used a fundamentally different type of technology.
Compare your IP with others in seconds, ensuring that you’re using the correct models and nobody else is using your designs. Promptly determine if a 3D object matches your standards, allowing you to get to market quicker. Find any 3D object in seconds, old or new, helping to keep department and operation costs to a minimum. Compare any two models instantly and see exactly how much they match with total accuracy and reliability. We call those facets. Everything in nature can be broken down into triangles. We basically analyze the relationship of facets to each other and to the surrounding environment.”